Skip to main content
. 2021 Mar 11;9:635189. doi: 10.3389/fcell.2021.635189

FIGURE 3.

FIGURE 3

Summary of strategies (and exemplar agents) for the therapeutic targeting of interactions between myeloid malignancies and BM vascular niche components.